1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid CAS: 2227589-22-0
| Product Parameters | |
|---|---|
| Catalog No. | BK6FP9 |
| CAS.RN | 2227589-22-0 |
| Molecular Formula | C13H15FN2O3 |
| Molecular Weight | 266.27 g/mol |
| Purity | NLT 98% |
Product Overview
1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid is a structurally complex pharmaceutical intermediate widely used in the synthetic routes of innovative drugs such as antitumor and antiviral agents. It is suitable for process development and optimization from the early stages of drug research to pilot-scale production. This product has a well-defined chemical structure and stable functional group characteristics, making it a key starting material or intermediate that supports customers' needs in new drug applications, process validation, and commercial production, meeting the requirements of multi-stage applications from laboratory research to large-scale production.
Applications
- Intermediates for antitumor drug synthesis
- Raw materials for antiviral drug development
- Key components for drug molecule structure modification
- Materials for process route optimization research
- Raw materials for customized pharmaceutical synthesis projects
Quality & Supply Capability
English Name: 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid Properties: White to off-white solid, containing fluorine atoms, carbamoyl groups, and a cyclobutane carboxylic acid structure. It exhibits good thermal and chemical stability and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific details. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process service from sample supply, small-scale preparation, pilot-scale amplification to customized batch production. We can flexibly adjust purity standards, impurity control schemes, packaging specifications, and delivery cycles according to customer needs, and provide complete quality documentation support. Furthermore, we have a professional technical team that can provide customers with comprehensive technical support from laboratory R&D to scale-up production, helping customers efficiently advance process development, route optimization, and project transformation.
Why Choose Bioncan
Focused on pharmaceutical intermediates, with extensive experience in compound synthesis and process development. Full-scale supply capability, covering needs from laboratory to industrial production. Provides complete quality control documentation to ensure controllable and traceable product quality. Supports customized requirements, adjusting purity, impurity limits, and packaging according to customer specifications. Provides supporting process optimization and scale-up technologies to improve customer R&D efficiency and production conversion rates.
Intermediates of Lestaurtinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA757C | Lestaurtinib API | 111358-88-4 |
| BK08P6 | Methyl 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino) cyclobutanecarboxylate | 2227589-23-1 |
| BK6FP9 | 1-((3-fluoro-4-(methylcarbamoyl)phenyl)amino)cyclobutanecarboxylic acid | 2227589-22-0 |
| BK2FN6 | 1-Amino-1-cyclobutanecarboxylic acid hydrochloride | 98071-16-0 |
| BK0T66 | 4-Bromo-2-fluoro-N-methylbenzamide | 749927-69-3 |
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting
For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 2227589-22-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.